While TRAIL-R1 has been shown to be pro-apoptotic, TRAIL-R4 serves as a decoy receptor, blocking TRAIL-induced apoptosis, and has been shown to be downregulated in CLE relative to psoriasis and lichen planus (69, 78). Here, TNFRSF10D is linked to psoriasis.